Editas Get A Vetr Upgrade To Strong Buy

BENZINGA | on Mon, Mar 20, 4:51 PM

The Vetr crowd Monday upgraded their rating[1] for Editas Medicine Inc (NASDAQ: EDIT), from 4 stars (Buy), issued 313 days ago, to 5 stars (Strong Buy). Crowd sentiment at the time of the upgrade was mostly positive, with 80 percent of Vetr user ratings bullish. Editas has traded fairly sporadically over the course of March, which began with the stock entering a trough of over 18 percent to a low of $20.40. The stock rallied back above $26 with a mid-month announcement the company was enterin...

Read the full article

Semantic processing powered by OpenCalais

Use of the DailyMe service and DailyMe web site constitutes acceptance of the Company's Terms of Service and Privacy Policy.

© 2017 DailyMe, Inc. All rights reserved.